Zacks Research Reduces Earnings Estimates for AngioDynamics

AngioDynamics, Inc. (NASDAQ:ANGO – Free Report) – Stock analysts at Zacks Research dropped their Q3 2026 EPS estimates for AngioDynamics in a research report issued on Tuesday, March 25th. Zacks Research analyst D. Dey now forecasts that the medical instruments supplier will post earnings per share of ($0.05) for the quarter, down from their previous […]

Mar 29, 2025 - 07:26

AngioDynamics, Inc. (NASDAQ:ANGO – Free Report) – Stock analysts at Zacks Research dropped their Q3 2026 EPS estimates for AngioDynamics in a research report issued on Tuesday, March 25th. Zacks Research analyst D. Dey now forecasts that the medical instruments supplier will post earnings per share of ($0.05) for the quarter, down from their previous […]